New cancer therapies
Programme stream(s): Cancer discovery / underpinning research , Treatment
Programme session type(s): Recent Advances session
Speaker: Ian Collins, The Institute of Cancer Research, UK
Speaker: John Bell, University of Ottawa, Canada
Speaker: Allan Jordan, CRUK Manchester Institute, UK
Date and time: Tue 06-Nov-2018, 11:00-12:30
This session will cover several aspects of biological and small molecule cancer drug discovery, from target validation to preclinical development. Understand how the drug discovery process starts and progresses towards the clinic. The aim is to become familiar with different strategies to target cancer.